Jackson Thornton Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-740
Closed -$275K 301
2025
Q4
$275K Sell
740
-52
-7% -$17.6K 0.03% 217
2025
Q3
$287K Buy
+792
New +$246K 0.03% 194

Other funds holding ELV

Jackson Thornton Wealth Management's ELV Position: Q1 2026 in Review

Jackson Thornton Wealth Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 740 shares — an estimated $275K sold.

Jackson Thornton Wealth Management first reported a position in ELV in Q3 2025 and held it in 2 quarters. The position peaked at $287K in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Jackson Thornton Wealth Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Jackson Thornton Wealth Management sold 740 Elevance Health shares in Q1 2026, an estimated $275K.
  • Jackson Thornton Wealth Management first reported a position in Elevance Health in Q3 2025 and held it in 2 quarters.
  • Jackson Thornton Wealth Management's Elevance Health position peaked at $287K in Q3 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.